BioTech Health X
  • BioTech News
  • BioTech CEO Interviews
  • Contact Us
Archives
  • December 2025
  • November 2025
  • October 2025
  • September 2025
  • August 2025
  • July 2025
  • June 2025
  • May 2025
  • March 2025
  • February 2025
  • January 2025
  • December 2024
  • November 2024
  • September 2024
  • August 2024
  • July 2024
  • May 2024
  • April 2024
  • December 2023
  • October 2023
  • August 2023
  • September 2022
  • August 2022
  • July 2022
  • June 2022
  • May 2022
  • April 2022
  • March 2022
  • February 2022
  • December 2021
  • November 2021
  • September 2021
  • August 2021
  • July 2021
  • June 2021
  • May 2021
  • April 2021
BioTech Health X
  • BioTech News
  • BioTech CEO Interviews
  • Contact Us
Subscribe

BioTech Health X

614 posts

Biotech NewsWest Pharmaceutical Services (WST) Could Outperform as Analysts Project $350.77 Price Target

  • BioTech Health X
  • December 2, 2025
West Pharmaceutical Services Inc. (NYSE:WST) is one of the most established and influential companies in the global pharmaceutical…
0 Shares
0
0
0
0
0
0
0

Biotech NewsDon’t Let the 70.7% YTD Jump Fool You—Axsome Therapeutics (AXSM) Still Faces Massive Downside Risk

  • BioTech Health X
  • December 2, 2025
Axsome Therapeutics (NASDAQ:AXSM) is a clinical-stage biopharmaceutical company that has grown into one of the most closely watched…
0 Shares
0
0
0
0
0
0
0

Biotech NewsTG Therapeutics (TGTX) Reports Explosive Q3 Revenue Surge to $161.7M as BRIUMVI Dominates MS Market

  • BioTech Health X
  • December 2, 2025
TG Therapeutics Inc. (NASDAQ:TGTX) is a biopharmaceutical company built on a vision to transform the treatment landscape for…
0 Shares
0
0
0
0
0
0
0

Biotech NewsAbbott Laboratories (ABT) Posts Stunning 21% EPS Growth—Is This the Strongest Healthcare Stock of 2025?

  • BioTech Health X
  • December 2, 2025
Abbott Laboratories(NYSE:ABT) is one of the most established and influential healthcare companies in the world, with a history…
0 Shares
0
0
0
0
0
0
0

Biotech NewsFennec Pharmaceuticals (FENC) Reveals Stunning Japan Trial Data—Hearing Loss Drops from 63% to Just 24%

  • BioTech Health X
  • December 2, 2025
Fennec Pharmaceuticals (NASDAQ:FENC) is a specialty pharmaceutical company built on the mission of addressing one of the most…
0 Shares
0
0
0
0
0
0
0

Biotech NewsJANUX Therapeutics Just Hit Its Lowest Price Since 2024 — Here’s Why Wall Street Is Still Bullish

  • BioTech Health X
  • December 2, 2025
Janux Therapeutics is a clinical-stage biotechnology company built on the vision of transforming cancer treatment through next-generation, tumor-activated…
0 Shares
0
0
0
0
0
0
0

Biotech NewsAcadia Healthcare (ACHC) Faces 168% Spike in Claims — Investors Ask: Panic or Massive Buying Opportunity?

  • BioTech Health X
  • December 2, 2025
Acadia Healthcare Company has grown into one of the largest and most influential behavioral health systems in the…
0 Shares
0
0
0
0
0
0
0

Biotech NewsAstera Labs (ALAB) Surges as New NVLink Fusion Breakthrough Redefines AI Infrastructure

  • BioTech Health X
  • December 2, 2025
Astera Labs (NASDAQ:ALAB) was founded with a singular vision: to solve one of the most fundamental bottlenecks in…
0 Shares
0
0
0
0
0
0
0

Biotech NewsCVS Health (CVS) Skyrockets 27% in 6 Months as MBR Hits 92.8%

  • BioTech Health X
  • November 30, 2025
CVS Health Corporation (NYSE:CVS) has evolved into one of the most influential and vertically integrated healthcare companies in…
0 Shares
0
0
0
0
0
0
0

Biotech NewsTenax Therapeutics (TENX) Sets 2026 Catalyst With 230-Patient Phase 3 Completion Target

  • BioTech Health X
  • November 30, 2025
Tenax Therapeutics (NASDAQ:TENX) is a late-stage, development-focused biopharmaceutical company built on a long-standing mission to address some of…
0 Shares
0
0
0
0
0
0
0

Biotech NewsCDT Equity (CDT) Surges After Company Boosts Bitcoin Holdings to 17.9 BTC — Is a Breakout Coming?

  • BioTech Health X
  • November 28, 2025
CDT Equity Inc. (NASDAQ:CDT), formerly known as Conduit Pharmaceuticals, is a uniquely structured, data-driven biopharmaceutical development company built…
0 Shares
0
0
0
0
0
0
0

Biotech NewsMicrobot Medical (MBOT) Surges 9.04% After FDA Breakthrough—LIBERTY™ System Set for 2026 Launch

  • BioTech Health X
  • November 28, 2025
Microbot Medical Inc. (NASDAQMBOT) is a pioneering medical technology company committed to transforming the future of minimally invasive…
0 Shares
0
0
0
0
0
0
0

Biotech NewsQuince (QNCX) Explodes 59% in 7 Days — Is Quince Therapeutics Headed for a Major Breakout?

  • BioTech Health X
  • November 28, 2025
Quince Therapeutics Inc. (NASDAQ:QNCX) is a clinical-stage biopharmaceutical company built on a foundation of scientific reinvention and strategic…
0 Shares
0
0
0
0
0
0
0

Biotech NewsMobile-health Network Solutions (MNDR) Skyrockets 33.69% After Announcing Massive Malaysia AI Data Center Expansion

  • BioTech Health X
  • November 28, 2025
Mobile-health Network Solutions (NASDAQ:MNDR) is an emerging player in the global digital health and AI-enabled healthcare ecosystem, established…
0 Shares
0
0
0
0
0
0
0

Biotech NewsCEL-SCI (CVM) Surges as Investors Revisit 10-Year Phase 3 Data and Multikine’s 14.1% OS Benefit

  • BioTech Health X
  • November 26, 2025
Cel-Sci Corporation (NYSE:CVM) is a long-established biotechnology company built on a singular mission: to transform the treatment of…
0 Shares
0
0
0
0
0
0
0

Biotech NewsTrevi Therapeutics (TRVI) Narrows Q3 Loss to $11.8M as Haduvio Advances Toward Major Milestone

  • BioTech Health X
  • November 26, 2025
Trevi Therapeutics, Inc. (NASDAQ:TRVI) is a clinical-stage biopharmaceutical company founded with a mission to develop transformative therapies for…
0 Shares
0
0
0
0
0
0
0

Biotech NewsSilexion Therapeutics (SLXN) Targets KRAS Mutation Market Worth $5.8B—Here’s Why Investors Are Watching Closely

  • BioTech Health X
  • November 26, 2025
Silexion Therapeutics Corp. (NASDAQ:SLXN) is a clinical-stage, oncology-focused biotechnology company built on a clear mission: to develop transformative,…
0 Shares
0
0
0
0
0
0
0

Biotech NewsQuantum BioPharma (QBIO) Emerges as Precision Medicine Breakthrough Leader

  • BioTech Health X
  • November 26, 2025
Quantum BioPharma (NASDAQ:QBIO) is an emerging biotechnology company built on a foundation of precision medicine, advanced molecular engineering,…
0 Shares
0
0
0
0
0
0
0
Recent Posts
  • West Pharmaceutical Services (WST) Could Outperform as Analysts Project $350.77 Price Target
  • Don’t Let the 70.7% YTD Jump Fool You—Axsome Therapeutics (AXSM) Still Faces Massive Downside Risk
  • TG Therapeutics (TGTX) Reports Explosive Q3 Revenue Surge to $161.7M as BRIUMVI Dominates MS Market
  • Abbott Laboratories (ABT) Posts Stunning 21% EPS Growth—Is This the Strongest Healthcare Stock of 2025?
  • Fennec Pharmaceuticals (FENC) Reveals Stunning Japan Trial Data—Hearing Loss Drops from 63% to Just 24%
Recent Comments
  • Novavax Announces Robust First Quarter 2024 Results and Strategic Partnerships • BioTech Health X on Novavax and Sanofi Forge $1.2 Billion Alliance to Boost COVID and Flu Vaccine Efforts
  • Thomas Shentz on Cellarity Expands Leadership Team to Continue Evolution of Breakthrough Platform to Encode Biology and Purposefully Create New Drugs
  • Tomasz Michałowski on Exclusive: Cel-Sci CEO Geert Kersten Talks Multikine, FDA Approval, CVM Future
  • Presenters Announced for 2021 William Blair Biotech Conference • BioTech Health X on William Blair Biotech Focus Conference 2021 Panel Schedule
Featured Posts
    • December 2, 2025
    West Pharmaceutical Services (WST) Could Outperform as Analysts Project $350.77 Price Target
    • December 2, 2025
    Don’t Let the 70.7% YTD Jump Fool You—Axsome Therapeutics (AXSM) Still Faces Massive Downside Risk
    • December 2, 2025
    TG Therapeutics (TGTX) Reports Explosive Q3 Revenue Surge to $161.7M as BRIUMVI Dominates MS Market
    • December 2, 2025
    Abbott Laboratories (ABT) Posts Stunning 21% EPS Growth—Is This the Strongest Healthcare Stock of 2025?
    • December 2, 2025
    Fennec Pharmaceuticals (FENC) Reveals Stunning Japan Trial Data—Hearing Loss Drops from 63% to Just 24%
Recent Posts
  • NeOnc Technologies (NTHI) Stuns Wall Street With Breakthrough 21% Response Rate in Brain Cancer Trial
    • November 26, 2025
  • Annovis Bio (ANVS) Director Buys 34,000 Shares—Is This the Biggest Insider Bullish Signal of 2025?
    • November 26, 2025
  • Surrozen (SRZN) Surges as Wnt Regeneration Pipeline Targets Wet AMD and DME
    • November 26, 2025
Categories
  • BioTech CEO Interviews (9)
  • Biotech Info (5)
  • Biotech News (599)
  • Uncategorized (1)
BioTech Health X
Designed & Developed by BioTech Health X
  • About BioTech Health X
  • List of Modern Life Science Technologies
  • Biotechnology Company Directory – List of Major Biotech Companies
  • Contact Us
  • Privacy Policy

Subscribe to
Our Updates

Back to top